本文選題：樹突狀細(xì)胞 + 細(xì)胞因子雞尾酒　； 參考：《安徽醫(yī)科大學(xué)》2013年碩士論文

【摘要】：目的：探討優(yōu)化人γhG-CSF動(dòng)員的外周血采集物來源的樹突狀細(xì)胞（dendritic cell，DC）成熟誘導(dǎo)條件，以便制備更有效的DC疫苗應(yīng)用于臨床，觀察并比較不同誘導(dǎo)條件下制備的DC疫苗在體外特異性抗腫瘤免疫反應(yīng)的能力。 方法：利用密度梯度離心法從重組人粒細(xì)胞集落刺激因子（γhG-CSF）動(dòng)員的外周血采集物分離出單個(gè)核細(xì)胞，以重組人粒細(xì)胞-巨噬細(xì)胞集落刺激因子(γhGM-CSF)和重組人白細(xì)胞介素-4(γhIL-4)體外誘導(dǎo)成不成熟樹突狀細(xì)胞（imDC），分別采用傳統(tǒng)細(xì)胞因子雞尾酒（IL-1β、IL-6、TNF-α、PGE2）和改良細(xì)胞因子雞尾酒（IL-1β、IL-6、TNF-α、polyI:C、CpG ODN）刺激成熟，并設(shè)有對(duì)照組（只加IL-4、GM-CSF）。3d后收獲成熟DC，觀察細(xì)胞形態(tài)、流式細(xì)胞儀檢測(cè)DC的內(nèi)吞能力通過異硫氰酸熒光素標(biāo)記的葡聚糖（FITC-Dextran）、檢測(cè)DC表面CD83、CD1a、CD80、HLA-DR、CD86和CCR-7，酶聯(lián)免疫吸附法（ELISA）檢測(cè)其IL-12、IL-10的分泌，MTT法檢測(cè)其刺激淋巴細(xì)胞增殖能力。實(shí)驗(yàn)中三組DC分別轉(zhuǎn)染A549細(xì)胞的總RNA，酶聯(lián)免疫吸附法（ELISA）檢測(cè)IFN-γ的分泌，乳酸脫氫酶(LDH)釋放法測(cè)定殺傷腫瘤活性。 結(jié)果：傳統(tǒng)細(xì)胞因子雞尾酒（IL-1β、IL-6、TNF-α、PGE2）和改良細(xì)胞因子雞尾酒（IL-1β、IL-6、TNF-α、polyI:C、CpG ODN）兩種方法均能誘導(dǎo)DC成熟，以改良細(xì)胞因子雞尾酒效果更佳，對(duì)照組幾乎不誘導(dǎo)DC成熟。改良雞尾酒方法誘導(dǎo)的成熟DC的FITC-Dextran內(nèi)吞能力明顯下降；DC成熟的表面標(biāo)志物CD83、CD1a的表達(dá)率分別是84.44%、87.94%（P0.05）；IL-12分泌量明顯增高（P 0.05）；IL-10分泌量明顯增高（P 0.05）；成熟DC能有效的刺激T淋巴細(xì)胞增殖；轉(zhuǎn)染A549細(xì)胞的總RNA后的改良組DC的IFN-γ分泌水平明顯高于前兩組（P 0.05），并能誘導(dǎo)腫瘤特異性CTL的產(chǎn)生進(jìn)而殺傷腫瘤細(xì)胞。 結(jié)論：從經(jīng)γhG-CSF動(dòng)員的外周血采集物中利用密度梯度離心法分離誘導(dǎo)出具備典型形態(tài)和免疫表型的DC后，兩種方法誘導(dǎo)DC成熟，實(shí)驗(yàn)證明改良細(xì)胞因子雞尾酒法是誘導(dǎo)DC成熟的最佳方法。
[Abstract]:Objective: to study the maturation induction conditions of dendritic cells derived from peripheral blood samples mobilized by human 緯 hG-CSF in order to prepare more effective DC vaccine for clinical application.To observe and compare the specific anti-tumor immune response of DC vaccine prepared under different induction conditions in vitro.Methods: mononuclear cells were isolated from peripheral blood samples mobilized by recombinant human granulocyte colony stimulating factor (緯 hG-CSF) by density gradient centrifugation.Immature dendritic cells (imDCA) were induced by recombinant human granulocyte-macrophage colony stimulating factor (緯 hGM-CSF) and recombinant human interleukin-4 (緯 hIL-4) in vitro. The mature cells were stimulated by traditional cytokine IL-1 尾 -IL-6TNF- 偽 PGE2 and modified cytokine cocktail IL-1 尾 IL-6TNF- 偽 polyCCpG ODN.The control group (IL-4 + GM-CSFN. 3 d) was used to harvest the mature DCs and observe the morphology of the cells.The endocytosis of DC was detected by flow cytometry by FITC-Dextranan labeled with fluorescein isothiocyanate, HLA-DRCD86 and CCR-7 by CD83T CD1a1 + CD80 on the surface of DC, and IL-12 IL-10 by MTT assay by enzyme linked immunosorbent assay (Elisa).In the experiment, the total RNAs of A549 cells transfected with three groups of DC were detected by enzyme linked immunosorbent assay (Elisa) to detect the secretion of IFN- 緯, and the activity of killing tumor was determined by lactate dehydrogenase (LDH) release method.The FITC-Dextran endocytosis of mature DC induced by modified cocktail method was significantly decreased. The expression rates of CD83- CD1a, the surface marker of DC maturation, were 84.444.444.44 / 87.94A and 87.94A respectively. The secretion of IL-12 was significantly increased in mature DCs, and the secretion of IL-10 was significantly increased in mature DCs, and the proliferation of T lymphocytes was effectively stimulated by mature DCs.The level of IFN- 緯 secretion in the modified DC after total RNA transfection was significantly higher than that in the former two groups (P 0.05), and it could induce the production of tumor-specific CTL and then kill the tumor cells.Conclusion: dendritic cells with typical morphology and immunophenotype were isolated from peripheral blood samples mobilized by 緯 hG-CSF by density gradient centrifugation.It is proved that the modified cytokine cocktail method is the best method to induce DC maturation.
【學(xué)位授予單位】：安徽醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類號(hào)】：R392

【相似文獻(xiàn)】

中國(guó)期刊全文數(shù)據(jù)庫(kù) 前10條

1 沈定文,羅金萍,李雍龍;SEA致敏樹突狀細(xì)胞免疫小鼠Th1/Th2細(xì)胞因子[J];中國(guó)公共衛(wèi)生;2005年09期

2 才子斌;王芳;李薇;趙恒軍;林海;王冠軍;;體外誘導(dǎo)人骨髓單個(gè)核細(xì)胞生成樹突狀細(xì)胞的實(shí)驗(yàn)研究[J];中國(guó)老年學(xué)雜志;2007年08期

3 楊春;吳雨崗;;胃癌患者外周血樹突狀細(xì)胞的體外擴(kuò)增、鑒定及內(nèi)吞能力測(cè)定[J];江蘇醫(yī)藥;2007年09期

4 王輝;周伯平;楊桂林;陳心春;樂曉華;劉艷;張路坤;Saul Tzipori;馮漢平;;隱孢子蟲對(duì)小鼠樹突狀細(xì)胞功能的影響[J];中國(guó)熱帶醫(yī)學(xué);2007年12期

5 賴思含;范霞;魏強(qiáng);楊雪;王希;鮑依稀;梁華平;;吳茱萸堿對(duì)小鼠樹突狀細(xì)胞分泌細(xì)胞因子的影響[J];中國(guó)免疫學(xué)雜志;2010年09期

6 穆義英;張栩;;慢性乙型肝炎細(xì)胞免疫研究進(jìn)展[J];寧夏醫(yī)學(xué)院學(xué)報(bào);2008年01期

7 茹穎;宋紅梅;李航;崔巍;;TNF-α促進(jìn)樹突狀細(xì)胞分化成熟的實(shí)驗(yàn)研究[J];中國(guó)實(shí)驗(yàn)血液學(xué)雜志;2010年05期

8 董偉;唐彥君;劉寧;;植物乳桿菌胞外多糖對(duì)小鼠樹突狀細(xì)胞分泌的調(diào)控[J];中國(guó)乳品工業(yè);2011年06期

9 張琳;周健;蔣東霞;;伊馬替尼對(duì)人CD34~+來源樹突狀細(xì)胞體外分化和功能的影響[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2006年04期

10 余雪姣;鄭曉群;鄭昭t，

本文編號(hào)：1733977